UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Immunological reviews, ISSN 0105-2896, 11/2017, Volume 280, Issue 1, pp. 74 - 82
damage associate molecular pattern (DAMP) | innate immunity | inflammation | immunogenic cell death (ICD) | adaptive immunity | tissue repair | Life Sciences & Biomedicine | Immunology | Science & Technology | Adaptive Immunity | Animals | Oxidation-Reduction | Humans | Cell Death | DNA Damage - immunology | HMGB1 Protein - immunology | Inflammation - immunology | Wound Healing | Immunity, Innate | Inflammation | Chromosomal proteins | Cell death | Stem cells | Cell proliferation | Lysosomes | Macrophages | Tissues | Nuclei | Immunity | HMGB1 protein | Proteins | Receptors | Cell activation | Moisture content | Oxidation | Repair | Immune system | Antigens | Immunological memory | Immune response | Adaptive immunity | Switching | Damage patterns | Immunogenicity | Healing | Cytoplasm | Tumors | Cancer | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9758, pp. 2075 - 2085
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Immunopathology | General aspects | Pharmacology. Drug treatments | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Middle Aged | Pyrazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Boronic Acids - adverse effects | Dexamethasone - adverse effects | Male | Transplantation, Autologous | Multiple Myeloma - drug therapy | Adult | Female | Boronic Acids - administration & dosage | Chemotherapy, Adjuvant | Multiple Myeloma - surgery | Thalidomide - adverse effects | Reoperation | Bortezomib | Dexamethasone - administration & dosage | Drug Administration Schedule | Multiple Myeloma - diagnosis | Kaplan-Meier Estimate | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Thalidomide - administration & dosage | Remission Induction | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - methods | Pyrazines - adverse effects | Italy | Aged | Complications and side effects | Dexamethasone | Multiple myeloma | Dosage and administration | Drug therapy | Thalidomide | Studies | Heart failure | Consolidation | Heart attacks | Data collection | Clinical medicine | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 8, pp. 810 - 816
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Urothelium - pathology | Urologic Neoplasms - pathology | Angiogenesis Inhibitors - administration & dosage | Urologic Neoplasms - drug therapy | Time Factors | Angiogenesis Inhibitors - therapeutic use | Female | Angiogenesis Inhibitors - adverse effects | Risk Assessment | Administration, Oral | Pyrimidines - administration & dosage | Urologic Neoplasms - mortality | Risk Factors | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Linear Models | Treatment Outcome | Tumor Burden | Disease-Free Survival | Cisplatin - therapeutic use | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Italy | Aged | Urothelium - drug effects | Sulfonamides - administration & dosage | Care and treatment | Endothelial growth factors | Oncology, Experimental | Research | Angiogenesis inhibitors | Vascular endothelial growth factor | Cancer | Index Medicus
Journal Article
Biology and fertility of soils, ISSN 0178-2762, 7/2015, Volume 51, Issue 5, pp. 625 - 635
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 12, pp. 2077 - 2084
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Pyrazines - administration & dosage | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Genes, Immunoglobulin Heavy Chain | Neoplasm, Residual | Stem Cell Transplantation | Multiple Myeloma - drug therapy | Time Factors | Polymerase Chain Reaction | Adult | Female | Boronic Acids - administration & dosage | Chemotherapy, Adjuvant | Multiple Myeloma - surgery | Bortezomib | Dexamethasone - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Thalidomide - administration & dosage | Chi-Square Distribution | Disease-Free Survival | Multiple Myeloma - pathology | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Italy | Aged | Multiple Myeloma - genetics | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 8, pp. 986 - 993
Life Sciences & Biomedicine | Oncology | Science & Technology | Immunopathology | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Tumors | Multiple Myeloma - mortality | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Warfarin - adverse effects | Male | Antineoplastic Agents - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Warfarin - therapeutic use | Fibrinolytic Agents - adverse effects | Multiple Myeloma - drug therapy | Thromboembolism - prevention & control | Time Factors | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Cardiovascular Diseases - mortality | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Cardiovascular Diseases - etiology | Risk Assessment | Multiple Myeloma - complications | Risk Factors | Anticoagulants - therapeutic use | Treatment Outcome | Thromboembolism - etiology | Thromboembolism - mortality | Thalidomide - administration & dosage | Anticoagulants - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Italy | Aged | Hemorrhage - chemically induced | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 10/2007, Volume 25, Issue 28, pp. 4459 - 4465
Immunopathology | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Tumors | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Thalidomide - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Melphalan - adverse effects | Drug-Related Side Effects and Adverse Reactions | Female | Melphalan - pharmacology | Thalidomide - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Administration, Oral | Thalidomide - administration & dosage | Maximum Tolerated Dose | Melphalan - administration & dosage | Multiple Myeloma - pathology | Survival Analysis | Prednisone - pharmacology | Aged | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 5, pp. 800 - 807
Life Sciences & Biomedicine | Oncology | Science & Technology | Immunopathology | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Tumors | Multiple Myeloma - mortality | Humans | Middle Aged | Pyrazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Stem Cell Transplantation | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Time Factors | Doxorubicin - analogs & derivatives | Protease Inhibitors - administration & dosage | Female | Neoadjuvant Therapy | Boronic Acids - administration & dosage | Chemotherapy, Adjuvant | Multiple Myeloma - surgery | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Bortezomib | Dexamethasone - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Thalidomide - administration & dosage | Polyethylene Glycols - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Italy - epidemiology | Aged | Index Medicus
Journal Article
9.
Full Text
Ammonium nutrition as a strategy for cadmium mobilisation in the rhizosphere of sunflower
Plant and soil, ISSN 0032-079X, 5/2006, Volume 283, Issue 1/2, pp. 43 - 56
Quaternary ammonium compounds | Agricultural soils | Plant roots | Plants | Acid soils | Soil pollution | Soil acidification | Silty soils | Sunflowers | Life Sciences | nitrogen fertilisers | cadmium | DMPP | phytoextraction | Ecology | Plant Physiology | Plant Sciences | sunflower | Soil Science & Conservation | rhizosphere acidification | Cadmium | Nitrogen fertilisers | Sunflower | Rhizosphere acidification | Phytoextraction | Nutrition | Soils | Flowers & plants
Journal Article